Collectively, these results demonstrate that Sall4 overexpression inhibits CCA progression in the AY model by multiple mechanisms, including impairing HC-to-CCA lineage conversion; promoting clonal expansion of proliferative, steatotic, LPC-like intermediate cells; and enhancing death of AY-transfected cells. This evidence concerns the gene SALL4 and cholangiocarcinoma.